Tags: Multiple MyelomaCancerTreatmentRegimen ComparisonsPharmacist
Profile | Contacts | Recent Articles on Subject | |
---|---|---|---|
1 | 1387865 PharmaTimes PharmaTimes Media Ltd. Digital health news. Surrey, United Kingdom | NICE nod for Darzalex with lenalidomide and dexamethasone - about 1 year ago | |
2 | Amir Ali, PharmD, BCOP Pharmacy Times Clinical Hem/Onc Pharmacist. USC Assistant Professor. Founder of OncologySolutionsRx. Los Angeles, CA | Personalizing Treatments and Patient Education - 10 days ago Evaluating New Data for Transplant-Eligible Patients With NDMM: PERSEUS, IsKia, and GMMG HD7 - 24 days ago Real-World Considerations for New Therapies - about 1 month ago Impact of Transplant Eligibility on Treatment Selection - about 2 months ago | |
3 | John Pinching PharmaTimes Next-gen biopharma company. La Jolla, California | Scotland first in UK to approve new myeloma treatment - 2 months ago | |
4 | Adam Feuerstein STAT News Reporter at STATnews. Dog lover. Polk Award winner. Boston, Massachusetts | ||
5 | Alana Hippensteele, Managing Editor Pharmacy Times #pharmacy news, insights. CE provider. Cranbury, New Jersey | Advances in CAR T-Cell Therapy and Bispecifics for Relapsed/Refractory Multiple Myeloma - 25 days ago Relapsed/Refractory Multiple Myeloma Treatment Advances With Three BiTE Therapy Options - 8 months ago | |
6 | Mike Bassett MedPage Today Explains healthcare complexities. Not endorsements. New York, New York | Real World CAR T-Cell Therapy Outcomes 'Favorable' in Relapsed/Refractory Myeloma - about 1 month ago All-Oral Therapy Promising in Higher-Risk MDS, CMML - 10 months ago Novel Therapy Reduced Transfusion Dependence in Lower-Risk MDS - 12 months ago | |
7 | Amy Baxter Pharma Voice Scientist, inventor, former pediatrician. Atlanta, Georgia | ||
8 | Greg Laub MedPage Today Director of Video at MedPage Today. Screenwriter, previous managing editor. | Belantamab Mafodotin: The Comeback Drug in Multiple Myeloma - 5 months ago Why Some Myeloma Patients Refuse Stem Cell Transplant - 11 months ago | |
9 | Ian Ingram MedPage Today Deputy Managing Editor.
MedPage Today. New York, New York | FDA Approves Earlier Use of CAR-T Products for Myeloma - 7 months ago | |
10 | Ashley Gallagher, Associate Editor Pharmacy Times One of Cabra girls on GoggleboxIRL. Dublin City, Ireland |